TENX Buy Disclosure
Giordano Christopher Thomas · SEC Form 4 · Filed Sep 15, 2026
Buy
Calculated transaction value
$11.25K
Giordano Christopher Thomas CEO
TENX
Tenax Therapeutics
TENX
Transaction date
Sep 11, 2026
Public filing date
Sep 16, 2026
Filing lag
Filed 5 days later
TENX daily price context
Close on/before transaction
$1.86
Sep 11, 2026
Close before public filing
$1.83
Sep 15, 2026
Return since public filing
+4.89%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,000 shares @ $1.88
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001871714-26-000002
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$20.09K
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tenax Therapeutics, Inc. TENX | Buy | Sep 15, 2026 | $8.84K |
| Tenax Therapeutics, Inc. TENX Current | Buy | Sep 11, 2026 | $11.25K |